Table 3.
Harms of the screening programs examined in this study with various eligibility criteria.
| Strategy (age-start_stop_pack-years) | Average screening examinations per person screened | Average false-positive results per person screened | Overdiagnosed cases per 100ka | Overdiagnosis, percentage of screening-detected cases | Overdiagnosis, percentage of all cases | Radiation-induced lung cancers per 100ka | Radiation-induced breast cancers per 100ka,b |
| Age_45_72_PY20 | 16.1 | 5.9 | 46.9 | 20.0 | 5.8 | 21.1 | 4.8 |
| Age_45_72_PY30 | 16.1 | 5.8 | 37.6 | 20.1 | 5.2 | 15.7 | 3.7 |
| Age_45_77_PY20 | 17.1 | 5.8 | 50.8 | 20.4 | 5.3 | 21.1 | 4.8 |
| Age_45_77_PY30 | 16.9 | 5.7 | 40.8 | 20.5 | 4.7 | 15.9 | 3.7 |
| Age_50_72_PY20 | 13.6 | 5.7 | 42.1 | 18.6 | 6.0 | 13.7 | 3.7 |
| Age_50_72_PY30 | 13.9 | 5.7 | 34.2 | 18.9 | 5.4 | 10.5 | 3.1 |
| Age_50_77_PY20 | 14.7 | 5.7 | 46.3 | 19.3 | 5.5 | 13.7 | 3.7 |
| Age_50_77_PY30 | 14.8 | 5.6 | 37.8 | 19.6 | 4.9 | 10.7 | 3.1 |
| Age_55_72_PY20 | 11.3 | 5.5 | 36.8 | 17.6 | 6.4 | 8.4 | 3.0 |
| Age_55_72_PY30 | 11.3 | 5.5 | 30.6 | 18.2 | 5.9 | 6.5 | 2.6 |
| Age_55_77_PY20 | 12.5 | 5.5 | 41.3 | 18.4 | 5.8 | 8.5 | 3.0 |
| Age_55_77_PY30 (CMS) | 12.4 | 5.6 | 34.3 | 19.0 | 5.3 | 6.6 | 2.7 |
aNumbers are per 100 000 individuals (100k) at age 40 followed to death.
bThe number of radiation-induced breast cancers in female patients.